MarketPulse
B

$BSX

47 articles found
3 positive
42 negative
2 neutral
The Motley FoolThe Motley Fool··Eric Volkman

Boston Scientific Poised for 5X Growth as Aging Demographics Drive Demand

Boston Scientific positioned to capitalize on global aging through AFib, chronic pain, and Parkinson's treatments; recent acquisitions boost stroke capabilities.
BSXPENhealthcarevaluation
GlobeNewswire Inc.GlobeNewswire Inc.··The Portnoy Law Firm

Boston Scientific Faces Securities Fraud Investigation After Electrophysiology Miss

Boston Scientific faces securities fraud investigation after 17.6% stock drop triggered by weaker-than-expected electrophysiology division sales in Q4 2025 results.
BSXsecurities fraudclass action lawsuit
BenzingaBenzinga··Vandana Singh

Boston Scientific Suspends AXIOS Stent Devices Over Safety Concerns

Boston Scientific suspended AXIOS Stent devices after 167 serious adverse events and three deaths linked to deployment failures. FDA directed healthcare facilities to stop using affected devices.
BSXstent delivery devicesAXIOS stents
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Neuromodulation Device Market to Double by 2032 Amid Rising Neurological Disease Burden

Neuromodulation device market expected to double to $16.1 billion by 2032, driven by rising neurological diseases, technological advances, and regulatory support.
MDTBSXABTLIVNFDA approvalmarket growth
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Rigid Endoscopes Market Poised to Reach $11.52B by 2033 on Minimally Invasive Demand

Rigid endoscopes market to grow from $7.36B to $11.52B by 2033, driven by minimally invasive surgery demand and technological advances in imaging capabilities.
SYKMDTBSXmedical devicesambulatory surgery centers
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Pulmonary Artery Catheter Market Projected to Expand 60% Through 2035

Pulmonary artery catheter market projected to grow from $1.23B to $1.97B by 2035, driven by rising cardiovascular disease and expanding critical care infrastructure globally.
MDTBSXEWBDXTFXmedical devicescardiovascular disease
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider Research

Uterine Fibroid Treatment Market Poised for 7.63% Annual Growth Through 2033

Global uterine fibroid treatment market projected to grow 7.63% annually through 2033, reaching $9.43 billion. Growth driven by high disease prevalence and minimally invasive surgical advances.
JNJPFEABBVSYKMDT+9market growthminimally invasive procedures